Humacyte, Inc. recently announced positive long-term clinical results from its Symvess humanitarian program in Ukraine, showing high patency, zero infections, and 100% limb salvage in trauma patients, ...
Analysts have recently revised their consensus price target for lululemon athletica, decreasing it slightly from $198.36 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback